Effect of retransfusion of heparin remaining in the salvaged blood on postoperative blood loss in coronary artery bypass grafting: Comparison with homologous blood transfusion (running title: Postoperative blood loss in CABG)

Aghdaii, Nahid. and Kabiri, Majid. and Yazdanian, Forouzan. and Ghaffarinejad, Mohammad Hasan. (2012) Effect of retransfusion of heparin remaining in the salvaged blood on postoperative blood loss in coronary artery bypass grafting: Comparison with homologous blood transfusion (running title: Postoperative blood loss in CABG). Iranian Heart Journal, 13 (2). pp. 24-34.

[img]
Preview
Text
36.pdf

Download (192kB) | Preview
Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....

Abstract

Background: One of the typical problems of cell savers is the retransfusion of the heparin added to the system. The aim of this study was to determine whether or not heparin, remaining in the prepared sample of retransfusion blood, might be responsible for disturbance in coagulation and increase in blood loss. Methods: Fifty patients undergoing coronary artery bypass grafting surgery (CABG) were randomly divided into two groups: group C (n=25) received cell-saver blood and group H (n=25) received homologous blood. Volumes of the intraoperative autologous and homologous transfusion, activated clotting time (ACT) of the transfused bloods, and ACT and amount of blood loss in the patients were measured intra and postoperatively. Results: There was no statistical difference between the groups in terms of demographics, preoperative characteristics, or operative details. Cell saver was used in 25 cases, and the average volume of blood autotransfused was 504± 158 mL. A significant statistical difference was observed in the mean volumes (460±200 vs. 80±160 mL; P = 0.0001) of perioperative allogeneic blood transfusions between groups H and C. Despite significant further cell-saver blood transfusion (504± 158 cc vs. 338±123 cc; P=0.001) and a significantly longer ACT of cell-saver blood than homologous blood (959±85 sec vs. 478±58 sec; P =0.0001) intraoperatively, there was no significant difference between the two groups in terms of postoperative blood loss (510 ± 270 cc in group H vs. 454 ± 150 cc in group C; P =0.362). Conclusion: Utilization of a cell saver was safe, with no increased risk of bleeding despite heparin added to the system.

Item Type: Article
Additional Information: cited By
Uncontrolled Keywords: heparin, adult; allogeneic blood transfusion; article; blood autotransfusion; blood clotting; blood clotting time; blood salvage; blood transfusion; blood volume; clinical article; controlled study; coronary artery bypass graft; erythrocyte concentrate; female; human; male; patient safety; postoperative hemorrhage; postoperative period; randomized controlled trial; risk assessment; treatment outcome
Subjects: WG Cardiovascular System
QU Biochemistry
Divisions: Faculty of Medicine > Department of Clinical Sciences > Department of Anesthesiology
Depositing User: zahra bagheri .
Date Deposited: 15 Aug 2017 07:46
Last Modified: 06 Mar 2018 10:02
URI: http://eprints.skums.ac.ir/id/eprint/3017

Actions (login required)

View Item View Item